Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Relocating Lab Equipment, Managing GxP Compliance and Operational Readiness

A biotech pharma industry required the relocation of 30 analytical devices (such as LightCyclers, workbenches, centrifuges, etc.) to a new operational space. The relocation had to be executed with minimal downtime, ensuring that all equipment remained GxP compliant and operationally ready post-move. Zamann Pharma Support was brought in to plan, manage, and execute the equipment move while adhering to strict timelines and quality requirements.

Challenges Faced

A detailed GAP analysis in Quality Management Systems is essential for identifying process deficiencies effectively.
  • GxP Compliance: Ensuring all equipment met GxP validation and qualification requirements after relocation.
  • Requalification Timelines: Each piece of equipment required thorough testing and documentation approval to ensure operational readiness.
  • Operational Continuity: Downtime had to be minimized to prevent delays in analytical testing and release processes.

Zamann Pharma Support’s Approach

  • Pre-Move Risk Assessment: Conducted a risk assessment to identify critical equipment specifications and testing needs. Documented all devices and created contingency plans for alternative analytical testing if delays occurred.
  • Qualification and Validation: Developed change qualifications to validate equipment performance both before and after the move. Conducted pre-move testing to establish baseline specifications and post-move testing to verify readiness.
  • Structured Planning and Execution: Created a detailed relocation plan with timelines and milestones for requalification activities. Coordinated weekly meetings with stakeholders to monitor progress and address any challenges.
  • Documentation Management: Ensured all requalification documents were reviewed, approved, and archived promptly to meet GxP standards.

Results Achieved

  • Minimized Downtime: Equipment downtime was reduced to a minimum, allowing analytical testing to proceed without disruption.
  • GxP Compliance Maintained: All equipment met GxP compliance standards, validated through change qualification processes.
  • Operational Readiness Achieved: The relocated devices were requalified and approved on time, ensuring operational continuity.
  • Stakeholder Satisfaction: Clear planning and communication ensured alignment among all parties involved, delivering a smooth relocation.
Laboratory
GMP qualification and lifecycle validation activities including IQ, OQ, and PQ supporting inspection readiness in pharmaceutical manufacturing.
Services

Qualification and Validation for GMP Systems

Our team supports the planning, execution, and maintenance of qualification and validation activities, including IQ, OQ, and PQ, to keep GMP-regulated systems compliant and under control.

Read More

Contact Us

Need help? Don't hesitate to get in touch
Zamann pharma support is committed to protecting and respecting your privacy, and we’ll use your personal information to administer your account and to provide the products and services you requested from us.

FAQ

1. How can laboratories relocate multiple analytical instruments without losing validated status or interrupting regulated testing workflows?

Teams maintain validated status by applying a structured change control process before any physical move. First, they document baseline performance data for each instrument. Then, they execute a controlled transport procedure followed by post-move performance verification. As a result, the system preserves validated conditions and avoids gaps in analytical continuity that could impact regulated testing.

2. What is the most effective way to manage requalification of analytical equipment after relocation in a controlled laboratory environment?

The most effective approach combines pre-move qualification with post-move re-verification under a unified protocol. Teams define acceptance criteria in advance and execute identical test conditions after relocation. In addition, they align documentation review with QA approval workflows to ensure rapid release. Consequently, each device returns to operational status without delaying analytical schedules.

3. How do GxP laboratories minimize downtime during large-scale analytical equipment moves across facilities?

Laboratories reduce downtime by prioritizing critical instruments and building contingency testing capacity before relocation starts. Moreover, they sequence equipment movement based on analytical dependency, not physical layout. Parallel scheduling of qualification activities further shortens inactive periods. Therefore, testing operations continue with minimal disruption while maintaining full compliance with GxP requirements.